Joint Clinical Trials Office
A Randomized Phase 2 Trial of ASTX727 +/- Iadademstat in Accelerated/Blast-Phase Philadelphia Chromosome-Negative Myeloproliferative Neoplasms (MPNs)
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 14, 2026
A Phase II Trial of Durvalumab with Gemcitabine and Cisplatin as Neoadjuvant Therapy for High-Risk Resectable Intrahepatic Cholangiocarcinoma
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 30, 2026
A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of ITK Inhibitor Soquelitinib Versus Physician’s Choice Standard of Care Treatment (Selected Single Agent) in Participants with Relapsed/Refractory Peripheral T-cell Lymphoma
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 6, 2026
A Phase 1 study of BAL0891 as monotherapy and in combination with chemotherapy in patients with advanced solid tumors or relapsed or refractory acute myeloid leukemia
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 6, 2026
A Phase 1b/2, Multicenter, Randomized, Open-Label Study to Evaluate The Efficacy And Safety Of GSK5764227 Alone And In Combination In Participants With Previously Treated Advanced Unresectable Or Metastatic Gastrointestinal Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 6, 2026
A Randomized Study Evaluating 2 Dose Regimens of Dupilumab in Children ≥6 Months of Age Weighing ≥5 to <15 kg With Active Eosinophilic Esophagitis
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 9, 2026
Pulmonary Segmentectomy for Lung Cancer: A Real-World International Registry-TSOG 108
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 9, 2026
A Phase 3 randomized open-label study of belantamab mafodotin in combination with lenalidomide and dexamethasone versus daratumumab, lenalidomide, and dexamethasone in participants with newly diagnosed multiple myeloma who are ineligible for auto-SCT
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 11, 2026
Prospective randomized study of the Kono-S anastomosis versus the side-to-side functional end anastomosis in the prevention of post-operative recurrence of Crohn’s disease
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 30, 2026
GS-US-567-6968: Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 31, 2026